Toxicity evaluation of choline ionic liquid-based nanocarriers of pharmaceutical agents for lung treatment

J Biomed Mater Res B Appl Biomater. 2023 Jul;111(7):1374-1385. doi: 10.1002/jbm.b.35241. Epub 2023 Mar 2.

Abstract

In vitro cytotoxicity evaluation of linear copolymer (LC) containing choline ionic liquid units and its conjugates with an antibacterial drug in anionic form, that is, p-aminosalicylate (LC_PAS), clavulanate (LC_CLV), or piperacillin (LC_PIP) was carried out. These systems were tested against normal: human bronchial epithelial cells (BEAS-2B), and cancers: adenocarcinoma human alveolar basal epithelial cells (A549), and human non-small cell lung carcinoma cell line (H1299). Cells viability, after linear copolymer LC and their conjugates addition for 72 h, was measured at concentration range of 3.125-100 μg/mL. The MTT test allowed the designation of IC50 index, which was higher for BEAS-2B, and significantly lower in the case of cancer cell lines. The cytometric analyzes, that is, Annexin-V FITC apoptosis assay and cell cycle analysis as well as gene expression measurements for interleukins IL6 and IL8 were carried out, and showed pro-inflammatory activity of tested compounds toward cancer cells, while it was not observed against normal cell line.

Keywords: cytotoxicity; drug delivery systems; ionic conjugates; polymer nanocarriers; trimethylammonium ionic liquids.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Cell Line
  • Choline / pharmacology
  • Humans
  • Ionic Liquids* / pharmacology
  • Lung

Substances

  • Choline
  • Ionic Liquids
  • Antineoplastic Agents